TransMedics Group, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

TransMedics Group, Inc. reported Cash And Cash Equivalents At Carrying Value of $394.81 million for the year ending 2023.

  • TransMedics Group, Inc. showed an increase of +96.2% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from TransMedics Group, Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2024.
  • XBRL data for this metric is available from 2018 to 2023 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2018 to 2023), TransMedics Group, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,850.6%.
  • Historical annual values: Fiscal year 2023: $394.81 million | Fiscal year 2022: $201.18 million | Fiscal year 2021: $25.58 million | Fiscal year 2020: $24.58 million | Fiscal year 2019: $20.09 million | Fiscal year 2018: $20.24 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: